Key Financial Data Of Reporting Company

株式会社PRISM BioLab - Filing #7262865

Concept 2024-10-01 to
2025-03-31
As at
2025-03-31
2023-10-01 to
2024-09-30
As at
2024-09-30
2023-10-01 to
2024-03-31
As at
2024-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
218,676,000 JPY
305,620,000 JPY
115,482,000 JPY
Ordinary profit (loss)
-432,376,000 JPY
-831,518,000 JPY
-322,855,000 JPY
Profit (loss)
-474,387,000 JPY
-1,049,514,000 JPY
-336,052,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
1,729,043,000 JPY
1,714,446,000 JPY
762,246,000 JPY
Net assets
3,057,707,000 JPY
3,502,901,000 JPY
2,311,962,000 JPY
Total assets
3,911,630,000 JPY
4,528,566,000 JPY
3,086,633,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-13.06
-33.53
-11.57
Diluted earnings per share
Equity-to-asset ratio
0.782 xbrli:pure
0.773 xbrli:pure
0.749 xbrli:pure
Net cash provided by (used in) operating activities
-696,518,000 JPY
150,144,000 JPY
340,140,000 JPY
Net cash provided by (used in) investing activities
-18,343,000 JPY
-244,187,000 JPY
-24,536,000 JPY
Net cash provided by (used in) financing activities
29,079,000 JPY
3,370,055,000 JPY
1,494,750,000 JPY
Cash and cash equivalents
3,736,718,000 JPY
4,392,022,000 JPY
2,960,261,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.